Volker Huppert

Chief Development Officer at Glycostem Therapeutics

Volker Huppert is a graduate bioprocess engineer from RWTH Aachen University. Among his achievements are participation in the set up of a quality system for a medical device/biotechnology company and development of several clinical-level reagents, disposable tubing sets and process software for cell separation and cell culture medical devices. He contributed to both the tubing set and process software development of a leading cell therapy-manufacturing device. Additionally, he managed projects and teams developing cell-manufacturing procedures for hematopoietic stem cells and Natural Killer cells. Huppert has published 12 papers in peer reviewed journals over the past 20 years while working for a leading biotechnology company and is co-inventor of 9 patent families, including methods for T cell depletion of hematopoietic stem cell products, NK-cell transduction and NK-cell proliferation.

Location

North Rhine-Westphalia, Germany

Links

Previous companies


Org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


G

Glycostem Therapeutics

1 followers

Glycostem is a clinical stage biotech company developing off-the shelf allogeneic cellular immunotherapy using Natural Killer (NK) cells.


Industries

Headquarters

Oss, Netherlands

Employees

11-50

Links